Headlines
-
Market sentiment positive
Monday | Nov 24 2025DEMAND is strong for pharmacists looking to buy pharmacies, according to the most recent results of the Attain Pharmacy Market Sentiment Survey, with data also suggesting that future supply is likely to increase in the next few years.
-
Is that the right vaccine?
Monday | Nov 24 2025PHARMACEUTICAL Defence Limited (PDL) is reminding pharmacists about the importance of covering off key checkpoints before administering a vaccine to ensure the correct one is provided.
-
-
Cooper’s legacy honoured
Friday | Nov 21 2025PHARMACY peak bodies came together alongside the University of Canberra Pharmacy School to host the inaugural Professor Gabrielle Cooper OAM Address in Canberra last night.
-
ABS finds health access improving
Friday | Nov 21 2025FEWER Australians are delaying or not using selected health services when needed compared to two years ago, according to new data released this week by the Australian Bureau of Statistics (ABS).
-
Guild Tassie winners named
Thursday | Nov 20 2025THE Pharmacy Guild of Australia Tasmania Branch celebrated outstanding contributors to community pharmacy at the 2026 Tasmania Community Pharmacy Awards, held in Hobart last night.
-
A way to go with med cannabis
Thursday | Nov 20 2025AUSTRALIAN consumers are increasingly embracing contemporary healthcare, including telehealth and medicinal cannabis, according to research commissioned by Montu healthcare group.
-
mRNA flu vax promise
Thursday | Nov 20 2025A NEW mRNA-based flu vaccine developed by Pfizer has been found to be 34.5% more effective against influenza-like illness compared to current flu vaccines, according to a new trial published in the New England Journal of Medicine.
-
Next stage for new CPD standards
Wednesday | Nov 19 2025PUBLIC consultation has closed for the Pharmaceutical Society of Australia's (PSA) Standards for Continuing Professional Development (CPD) for pharmacists, marking the next step in finalising the new CPD standards.
-
New BP combo med on PBS
Wednesday | Nov 19 2025ARROTEX Pharmaceuticals has announced the Pharmaceutical Benefits Scheme (PBS) listing of ARX-Telmisartan/Amlodipine, a new brand of fixed-dose combination therapy for the management of hypertension.
